These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15313907)

  • 41. Identification of gain-of-function variants of the human prolactin receptor.
    Goffin V; Bogorad RL; Touraine P
    Methods Enzymol; 2010; 484():329-55. PubMed ID: 21036240
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of prolactin on lactalbumin production by normal and malignant human breast tissue in organ culture.
    Wilson GD; Woods KL; Walker RA; Howell A
    Cancer Res; 1980 Feb; 40(2):486-9. PubMed ID: 6243254
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prolactin signaling mechanisms in ovary.
    Bouilly J; Sonigo C; Auffret J; Gibori G; Binart N
    Mol Cell Endocrinol; 2012 Jun; 356(1-2):80-7. PubMed ID: 21664429
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intramolecular disulfide bonds of the prolactin receptor short form are required for its inhibitory action on the function of the long form of the receptor.
    Xie YL; Hassan SA; Qazi AM; Tsai-Morris CH; Dufau ML
    Mol Cell Biol; 2009 May; 29(10):2546-55. PubMed ID: 19273600
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human prolactin receptors are insensitive to mouse prolactin: implications for xenotransplant modeling of human breast cancer in mice.
    Utama FE; LeBaron MJ; Neilson LM; Sultan AS; Parlow AF; Wagner KU; Rui H
    J Endocrinol; 2006 Mar; 188(3):589-601. PubMed ID: 16522738
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Human Intermediate Prolactin Receptor I-tail Contributes Breast Oncogenesis by Targeting Ras/MAPK Pathway.
    Shen S; Radhakrishnan SK; Harrell JC; Puchalapalli M; Koblinski J; Clevenger C
    Endocrinology; 2024 Apr; 165(6):. PubMed ID: 38713636
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of long-form prolactin receptor is associated with lower disease-free and overall survival in node-negative breast cancer patients.
    Sa-Nguanraksa D; Mitpakdi K; Samarnthai N; Thumrongtaradol T; O-Charoenrat P
    Gland Surg; 2021 Jan; 10(1):130-142. PubMed ID: 33633970
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prolactin receptor in breast cancer: marker for metastatic risk.
    Shemanko CS
    J Mol Endocrinol; 2016 Nov; 57(4):R153-R165. PubMed ID: 27658959
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prolactin receptors in rat cholangiocytes: regulation of level and isoform ratio is sex independent.
    Bogorad RL; Ostroukhova TY; Orlova AN; Rubtsov PM; Smirnova OV
    Biochemistry (Mosc); 2006 Feb; 71(2):178-84. PubMed ID: 16489923
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prolactin receptor expression and breast cancer: relationships with tumor characteristics among pre- and post-menopausal women in a population-based case-control study from Poland.
    Faupel-Badger JM; Duggan MA; Sherman ME; Garcia-Closas M; Yang XR; Lissowska J; Brinton LA; Peplonska B; Vonderhaar BK; Figueroa JD
    Horm Cancer; 2014 Feb; 5(1):42-50. PubMed ID: 24249584
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Prolactin--significance in benign and malignant breast diseases].
    Pavić Z; Pavić S
    Z Lymphol; 1988 Jul; 12(1):30-5. PubMed ID: 3051756
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gain-of-function Prolactin Receptor Variants Are Not Associated With Breast Cancer and Multiple Fibroadenoma Risk.
    Chakhtoura Z; Laki F; Bernadet M; Cherifi I; Chiche A; Pigat N; Bernichtein S; Courtillot C; Boutillon F; Bièche I; Vacher S; Tanguy ML; Bissery A; Grouthier V; Camparo P; Foretz M; Do Cruzeiro M; Pierre R; Rakotozafy F; Tichet J; Tejedor I; Guidotti JE; Sigal-Zafrani B; Goffin V; Touraine P
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4449-4460. PubMed ID: 27575941
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prolactin and prolactin binding sites in human breast cancer cells.
    Marchetti E; Rimondi AP; Querzoli P; Fabris G; Nenci I
    Prog Clin Biol Res; 1984; 142():109-17. PubMed ID: 6324233
    [No Abstract]   [Full Text] [Related]  

  • 54. Altered expression of prolactin receptor-associated signaling proteins in human breast carcinoma.
    McHale K; Tomaszewski JE; Puthiyaveettil R; Livolsi VA; Clevenger CV
    Mod Pathol; 2008 May; 21(5):565-71. PubMed ID: 18246042
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multiple new isoforms of the human prolactin receptor gene.
    Trott JF; Hovey RC; Koduri S; Vonderhaar BK
    Adv Exp Med Biol; 2004; 554():495-9. PubMed ID: 15384631
    [No Abstract]   [Full Text] [Related]  

  • 56. [The ratio of prolactin receptor isoforms in rat hepatocytes: the effect of obstructive cholestasis].
    Bogorad RL; Smyslova VS; Smirnov AN; Rubtsov PM; Smirnova OV
    Mol Biol (Mosk); 2002; 36(1):91-3. PubMed ID: 11862718
    [No Abstract]   [Full Text] [Related]  

  • 57. Multiple cell types in the oviduct express the prolactin receptor.
    Radecki KC; Ford MJ; Phillipps HR; Lorenson MY; Grattan DR; Yamanaka Y; Walker AM
    FASEB Bioadv; 2022 Jul; 4(7):485-504. PubMed ID: 35812077
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proceedings: Prolactin in human breast tumours.
    Cole EN; Golder MP; Griffiths K
    J Endocrinol; 1976 Jun; 69(3):49P. PubMed ID: 950542
    [No Abstract]   [Full Text] [Related]  

  • 59. [Cancer of the breast: is the role of prolactin proven?].
    Leger P
    Nouv Presse Med; 1978 Mar; 7(11):937. PubMed ID: 643561
    [No Abstract]   [Full Text] [Related]  

  • 60. [Editorial: Prolactin and breast cancer].
    Ben-David M; Biran S
    Harefuah; 1976 Apr; 90(7):336-9. PubMed ID: 1278799
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.